menu
    • menu

    Company profile for Abliva

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Abliva is dedicated to developing medicines for the treatment of mitochondrial disease, a rare and often severe congenital condition arising from malfunctions in the mitochondria, the cell's energy providers. The company's portfolio encompasses projects in various stages, spanning from early discovery to clinical phases. Abliva's primary focus is to emerge as a leading force in mitochondrial medicine, addressing both mitochond...
    Abliva is dedicated to developing medicines for the treatment of mitochondrial disease, a rare and often severe congenital condition arising from malfunctions in the mitochondria, the cell's energy providers. The company's portfolio encompasses projects in various stages, spanning from early discovery to clinical phases. Abliva's primary focus is to emerge as a leading force in mitochondrial medicine, addressing both mitochondrial diseases and orphan indications with significant unmet medical needs.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    AblivaSweden Flag
    Country
    Country
    Sweden
    Address
    Address
    Scheeletorget 1 Lund
    Telephone
    Telephone
    +46 0462756220
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://abliva.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/abliva
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Pharming Completes Cash Offer For Abliva, Extends Acceptance
    Pharming Completes Cash Offer For Abliva, Extends Acceptance

    07 Feb 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/02/07/3023002/0/en/Pharming-Technologies-B-V-declares-unconditional-and-completes-the-recommended-cash-offer-to-the-shareholders-of-Abliva-AB-publ-and-extends-the-acceptance-period.html

    GLOBENEWSWIRE
    07 Feb 2025
    Share Share
    Pharming pays $66M to for Abliva, mitochondrial disease med
    Pharming pays $66M to for Abliva, mitochondrial disease med

    16 Dec 2024

    // FIERCE PHARMA

    https://www.fiercebiotech.com/biotech/pharming-pays-66m-abliva-and-potential-blockbuster-mitochondrial-disease-med

    FIERCE PHARMA
    16 Dec 2024
    Share Share
    Pharming Announces Cash Offer for Abliva AB Shareholders
    Pharming Announces Cash Offer for Abliva AB Shareholders

    15 Dec 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/12/15/2997199/0/en/Pharming-announces-public-cash-offer-to-the-shareholders-of-Abliva-AB.html

    GLOBENEWSWIRE
    15 Dec 2024
    Share Share
    Abliva Reports Positive Interim Analysis Of KL1333 FALCON Study
    Abliva Reports Positive Interim Analysis Of KL1333 FALCON Study

    18 Jul 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/07/18/2915669/0/en/Abliva-Announces-Positive-Interim-Analysis-of-the-FALCON-Study-for-KL1333-in-Primary-Mitochondrial-Disease.html

    GLOBENEWSWIRE
    18 Jul 2024
    Share Share
    Abliva To Host KOL Event On KL1333 In Primary Mitochondrial Disease
    Abliva To Host KOL Event On KL1333 In Primary Mitochondrial Disease

    13 May 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/05/13/2880431/0/en/Abliva-to-Host-Virtual-KOL-Event-on-KL1333-in-Primary-Mitochondrial-Disease-on-May-21-2024.html

    GLOBENEWSWIRE
    13 May 2024
    Share Share
    Owl, Abliva Partner on Traumatic Brain Injury Drug
    Owl, Abliva Partner on Traumatic Brain Injury Drug

    20 Nov 2023

    // CONTRACT PHARMA

    https://www.contractpharma.com/contents/view_breaking-news/2023-11-20/owl-abliva-partner-on-traumatic-brain-injury-drug/?widget=listSection

    CONTRACT PHARMA
    20 Nov 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search